Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 1/20 | 0.43 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.43 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.37 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 5/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | CTH | P32929 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL391028 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6674512 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6674893 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL1402291 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6130185 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| Glycylglycylglycine SCHEMBL98565 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6677616 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL391787 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6120072 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL4586328 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17308 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | claimed |
| US-20260078190-A1 | Bispecific Tetravalent Antibodies and Methods of Making and Using Thereof | SYSTIMMUNE, INC. (US) | 2026-03-19 | — | — | US | claimed |
| EP-4684807-A1 | LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE | Duality Biologics (Shanghai) Co., Ltd. (CN) | 2026-01-28 | — | — | EP | claimed |
| US-12428483-B2 | Bispecific tetravalent antibodies and methods of making and using thereof | SYSTIMMUNE, INC. (US) | 2025-09-30 | — | — | US | claimed |
| US-12365945-B2 | Urinary microbiomic profiling | Convergent Genomics, Inc. (US) | 2025-07-22 | — | — | US | claimed |
| WO-2025151685-A1 | ANTIBODY-AURISTATIN DRUG CONJUGATE AND PHARMACEUTICAL USE THEREOF | SYSTIMMUNE, INC. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250228958-A1 | TSP1 INHIBITOR | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2025-07-17 | — | — | US | claimed |
| EP-4566632-A1 | MSLN ANTIBODY-DRUG CONJUGATE | Nona Biosciences (Suzhou) Co., Ltd. (CN) | 2025-06-11 | — | — | EP | claimed |
| CN-120082577-A | Method for controlling sgRNA intracellular localization and regulating gene expression | 广州医科大学 | 2025-06-03 | — | — | CN | claimed |
| US-20250135018-A1 | CAMPTOTHECIN PEPTIDE CONJUGATES | SEAGEN INC (US) | 2025-05-01 | — | — | US | claimed |
| EP-0514413-A1 | IMMUNOLOGICALLY ACTIVE PEPTIDES OR POLYPEPTIDES FROM THE PARVOVIRUS B19. | MIKROGEN MOLEKULARBIOL ENTW (DE) | 1992-11-25 | — | — | EP | claimed |
| WO-1992010575-A1 | BIFUNCTIONAL INHIBITORS OF THROMBIN AND PLATELET ACTIVATION | BIOGEN, INC. (US) | 1992-06-25 | — | — | WO | claimed |
| WO-1991012269-A1 | IMMUNOLOGICALLY ACTIVE PEPTIDES OR POLYPEPTIDES FROM THE PARVOVIRUS B19 | MIKROGEN MOLEKULARBIOLOGISCHE ENTWICKLUNGS-GMBH (DE) | 1991-08-22 | — | — | WO | claimed |
| US-5030240-A | Perhydrolysis; cleaning compounds | THE CLOROX COMPANY (US) | 1991-07-09 | — | — | US | claimed |
| WO-1991007499-A1 | THE SCL GENE, AND THE ENCODED HEMATOPOIETIC FACTOR | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1991-05-30 | — | — | WO | claimed |
| CN-87106313-A | The improvement of organic compound | — | 1988-05-04 | — | — | CN | claimed |
| WO-1988002023-A1 | RECOMBINANT LIGNINASE | SANDOZ AG (CH) | 1988-03-24 | — | — | WO | claimed |
| EP-0190254-A4 | CLONED GENE AND METHOD FOR MAKING AND USING THE SAME. | GENEX CORP (US) | 1987-03-09 | — | — | EP | claimed |
| EP-0190254-A1 | CLONED GENE AND METHOD FOR MAKING AND USING THE SAME | GENEX CORPORATION (US) | 1986-08-13 | — | — | EP | claimed |
| WO-1986000528-A1 | CLONED GENE AND METHOD FOR MAKING AND USING THE SAME | GENEX CORPORATION (US) | 1986-01-30 | — | — | WO | claimed |